Key takeaways
- 3 anchor institutions for GCC HAE diagnosis and management: KFSH&RC, AUH, and Hamad Medical Corporation
- 6-10 physicians in the entire GCC HAE specialist community, per SACIA membership records
- 1,200-1,500 estimated true GCC HAE patients; fewer than 200 confirmed regionwide
- 6 KOL Mapping gates (K1-K6), each independently verified before a name enters the workbook
SACIA sizes the entire GCC HAE specialist community at 6-10 physicians across three anchor institutions, evidence of how concentrated GCC HAE expertise for this disease actually is.
GCC HAE expertise concentrates around a small number of tertiary referral institutions, not a broad regional field. King Faisal Specialist Hospital and Research Centre (KFSH&RC), AUH, and Hamad Medical Corporation anchor the diagnostic and treatment pathway for an estimated 1,200 to 1,500 GCC HAE patients, of whom fewer than 200 are confirmed. That kind of concentrated referral structure does not happen without an established regional collaboration network, coordinated through SACIA (Saudi Allergy and Clinical Immunology Association), which our KOL Universe gate (K1) uses as the starting map of institutional concentration before any single physician is scored.
That structure changes how AXLRx tiers influence in the GCC. The entire regional specialist community numbers only 6 to 10 physicians, so a KOL working within one of the three anchor institutions carries different scientific weight than one working in isolation, and our Tier Classification gate (K2) scores that distinction directly, alongside SACIA membership and family-cascade-screening registry roles. No named individual enters the workbook without a verification tag; every KOL identity is checked against live publication records and institutional affiliations, then marked Verified, Industry benchmark, or Requires client validation. A commercial team engaging the wrong tier wastes MSL capacity across a physician community this small, which is exactly what the K1-K6 gate structure is built to prevent.
The GCC HAE specialist network — three anchor institutions, a 6-10 physician community
| Institution | Country | Role |
|---|---|---|
| King Faisal Specialist Hospital and Research Centre (KFSH&RC) | Saudi Arabia | HAE registry and family-cascade screening lead |
| AUH | United Arab Emirates | Specialist allergy/immunology referral |
| Hamad Medical Corporation | Qatar | Specialist allergy/immunology referral |
Sources: AXLRx GCC Hereditary Angioedema Disease Landscape and Launch-Readiness assessments; KFSH&RC HAE Registry 2022; SACIA membership directory.
What this workbook answers
Every section answers a named commercial question your team is asking, scoped to your asset.
- Which GCC institutions actually anchor HAE diagnosis and management, and how concentrated is that specialist community? • The three-institution anchor structure (KFSH&RC, AUH, Hamad Medical Corporation) • SACIA as the regional coordinating body • K1 KOL Universe Sizing methodology
- How does AXLRx tier scientific influence across a specialist community numbering only 6-10 physicians? • K2 Tier Classification methodology • SACIA membership and family-cascade-registry weighting • K3 Scientific Influence scoring inputs
- What verification standard does every named KOL have to clear before shipping in the workbook? • The three-tag verification protocol (Verified/Industry benchmark/Requires client validation) • live publication and institutional-affiliation cross-checks • why no placeholder name ships unflagged
What's inside
-
1 · The Binding Constraint 2 pp
- Why institutional concentration, not scattergun individual outreach, is the single variable this workbook sizes first
- Pressure-tested against the three-institution GCC anchor structure before the rest of the workbook is built out
-
2 · KOL Universe (K1) 4 pp
- Every GCC HAE KOL sized and sourced from publication and institutional-affiliation data
- The three-institution anchor structure (KFSH&RC, AUH, Hamad Medical Corporation) as the sizing anchor
- Universe boundaries: who counts as a KOL versus a high-volume prescriber
-
3 · Tier Classification (K2) 3 pp
- Scientific-influence scoring across SACIA membership and family-cascade-screening registry roles
- What separates a Tier 1 KOL from a high-volume community prescriber
-
4 · Scientific Influence (K3) 3 pp
- Influence inputs: SACIA membership, registry authorship, institutional role
- Cross-checked against independent publication and citation data
-
5 · Engagement Readiness (K4) 3 pp
- Readiness scoring and channel recommendations per KOL
- Sequencing implications for MSL deployment
-
6 · MSL Territory Coverage (K5) 3 pp
- Territory-to-KOL coverage map across Riyadh, Al Ain, Doha, and the rest of the GCC
- Where current MSL deployment has gaps
-
7 · Cross-Border Network (K6) 3 pp
- Multi-market reach for KOLs active beyond a single GCC country, across Saudi Arabia, UAE, and Qatar
- Implications for coordinated versus purely local engagement
-
8 · Client Alignment Questions 2 pp
- The open KOL-engagement questions your medical affairs team must close
- Structured for an internal alignment session before MSL deployment
Appendix and source ledger included · 45-minute analyst readout included with delivery
Custom workbook delivered in 72 hours.
Assess this reportIncluded with every brief
Get Started
Commission this workbook
AXLRx delivers KOL mapping workbooks built for medical affairs and commercial teams engaging GCC hereditary angioedema specialists. Custom workbook in 72 hours.
- 1. Submit your requestSpecify your indication, geography, and institution scope.
- 2. Scoping callAXLRx analyst confirms institution scope and verification standard before building.
- 3. DeliveryResearch-verified KOL workbook in 72 hours with optional analyst readout.
How AXLRx builds this workbook
Prepared by MoatRx analysts on the AXLRx commercial consulting engine.
Every AXLRx KOL workbook is built from live publication records and institutional-affiliation data, not secondary summaries. No KOL name ships without a verification tag.
GCC HAE KOL sources: the three-institution anchor structure (KFSH&RC, AUH, Hamad Medical Corporation) documented in the KFSH&RC HAE Registry 2022; the SACIA membership directory for the regional specialist-community size; and the GCC Allergy and Immunology Society HAE working group report 2022.
- Three-institution anchor structure and confirmed-case gap (fewer than 200 of an estimated 1,200-1,500 patients) verified against the KFSH&RC HAE Registry 2022 and the AXLRx GCC Hereditary Angioedema Disease Landscape assessment
- 6-10 physician specialist-community size verified against the SACIA membership directory, as cited in the AXLRx GCC Hereditary Angioedema Launch-Readiness assessment
- Every KOL entry in the underlying workbook carries a three-tag verification status before delivery: Verified, Industry benchmark, or Requires client validation
Frequently asked questions
Deliverables What formats are included with every workbook?
Every commissioned KOL Mapping workbook includes an editable 6-sheet Excel workbook (KOL Universe, Tier Scoring, Engagement Calendar, MSL Territory, Cross-Border Network, Evidence Register) and a PDF summary brief. No PowerPoint deck. This deliverable is built to be worked in directly. An optional 45-minute analyst readout call is included.
Sources How are KOL identities and rankings verified?
Every KOL entry is built from named-centre registry data, regional specialist-society membership records, and immunology working-group reporting, then tagged Verified, Industry benchmark, or Requires client validation. No name ships unverified.
Customisation Can I scope this to a specific GCC state or named-centre set?
Yes. The intake form captures your indication, geography, and institution scope. A scoping call confirms scope before research starts. Commission via the intake form to start.